HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 03-05-2008, 06:21 AM   #1
fullofbeans
Senior Member
 
Join Date: Jan 2007
Location: UK
Posts: 617
Ha sorry..hope I have not offended..
__________________

35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies

Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..

superior vena cava blocked: stent but face remains puffy

April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.

Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.



'Under no circumstances should you lose hope..' Dalai Lama
fullofbeans is offline   Reply With Quote
Old 03-05-2008, 09:01 AM   #2
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
my slow but steady info "mining" is yielding results

A case with complete resolution of multiple liver mets with the combination of capecitabine and herceptin :

Breast Cancer. 2007;14(3):297-301.
Complete remission of recurrent breast cancer with multiple liver metastases after oral capecitabine and injected trastuzumab.

Morohashi S, Odagiri H, Morohashi H, Kimura Y, Sasaki M.
Department of Surgery, Hirosaki University School of Medicine, Hirosaki, Japan. hm2002@cc.hirosaki-u.ac.jp
A 32-year-old woman underwent modified radical mastectomy for right breast cancer (invasive ductal carcinoma, f, INF beta, v0, ly1, pT2, pN1, M0, Stage II B ER (+/-), PR (-), Her2 (3+)) in June 2003, and received postoperative systemic adjunctive chemotherapy using epirubicin combined with cyclophosphamide, followed by paclitaxel. In August 2004, after a disease-free interval of 14 months, liver metastasis appeared, and therefore from September 2004, combination chemotherapy with oral capecitabine (2,400 mg/day) and injected trastuzumab (120 mg/week) was started. After 3 cycles, all the metastases responded and this marked response has been maintained for 16 months. This therapy is currently being continued (19 cycles), and no serious side effects have been encountered. Capesitabine and trastuzumab combination therapy is effective for recurrent breast cancer showing overexpression of HER2 and resistance to taxane, and can be considered as a first-line therapy for this purpose. It is anticipated that many cases treated with this regimen will be reported and discussed in the near future.
PMID: 17690508 [PubMed - indexed for MEDLINE]
Lani is offline   Reply With Quote
Old 03-05-2008, 11:23 AM   #3
HavahJ
Senior Member
 
Join Date: Dec 2005
Posts: 98
HavahJ

No problem.
HavahJ is offline   Reply With Quote
Old 03-05-2008, 11:27 AM   #4
HavahJ
Senior Member
 
Join Date: Dec 2005
Posts: 98
Hi Lani help- marker up 2000 points in 4 weeks.

Hi Lani, I've just started the second chemo, only been on two weeks.navelbine/hercep/xeloda/tykerb. What do you think this swift rise in tumor marker means? I can't believe what really hasn't been above 100 in 20 years. I think I should just stay on the chemo. I just had aCT a couple of weeks ago and A PET not that long ago. What could such a high marker mean. The CA27, 29 has always been completely accurate for me. Thank you HavahJ@aol.com (Jan)
HavahJ is offline   Reply With Quote
Old 03-05-2008, 12:23 PM   #5
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
I am in no way qualified to answer you

I am not an oncologist or oncologic nurse or any other professional with experience with chemo, have never had chemo myself and have no idea how quickly markers change

That sort of thing is rarely covered in articles...it seems to be part of the wealth of experience oncologists have from treating patients, which is why you should rely on them.

Have you found one you have faith in? Having faith in someone is not to say you should not to read the literature and not ask others on this board for input and then discuss items with him/her.

Others here can answer your specific questions better. I can just search the published literature.

Hopefully others with similar stories will chime in.
Lani is offline   Reply With Quote
Old 03-06-2008, 06:09 PM   #6
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Found this on the clinical trials board on this site

http://her2support.org/vbulletin/forumdisplay.php?f=29
Lani is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:23 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter